(Q37054785)

18 August 2017

1 reference

title

Circadian variation of fibrinolytic activity in blood (English)

1 reference

18 August 2017

Circadian Variation of Fibrinolytic Activity in Blood (English)

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

2 December 2022

0 references

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

2 December 2022

author name string

F. Andreotti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1818784

2 December 2022

C. Kluft

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1818784

2 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/07420529109059170

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Chronobiology International

2 December 2022

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

336-351

1 reference

Effect of age, sex, and diurnal variation on the human fibrinolytic system

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

Circadian timekeeping in health and disease. Part 2. Clinical implications of circadian rhythmicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07420529109059170

The biological significance of fibrinolysis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

2 December 2022

5

16

645

Fearnley GR

1957

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Diurnal fluctuation of plasma-fibrinolytic activity in normal males

2 December 2022

6

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Determination of fibrinolytic activity of whole blood. With special reference to the effects of exercise and fat feeding

2 December 2022

7

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Blood coagulation and fibrinolysis in relation to degree of physical activity during work and leisure time. A study based on a random sample of 54-year-old men

2 December 2022

13

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis

2 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke

2 December 2022

19

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

2 December 2022

23

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Chronobiology of coronary risk markers in Greenland Eskimos: a comparative study with Caucasians residing in the same Arctic area

2 December 2022

24

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Fibrinolytic activity and thromboembolism

2 December 2022

37

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction

2 December 2022

39

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Diurnal variation in plasma euglobulin activity and fibrinogen levels. Preliminary report

2 December 2022

42

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

British Journal of Rheumatology

2 December 2022

45

24

211

Keegan AL

1985

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Diurnal variations of fibrinolytic activity and plasma-11-hydroxycorticosteroid levels

2 December 2022

48

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

2 December 2022

55

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

2 December 2022

57

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Circadian variation in the frequency of sudden cardiac death

2 December 2022

62

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Circadian variation in pain onset in unstable angina pectoris

2 December 2022

63

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

Diurnal variation in occurrence of strokes

2 December 2022

64

1 reference

https://api.crossref.org/works/10.3109/07420529109059170

2 December 2022

Identifiers

1 reference

18 August 2017

1 reference